Homogeneous Extraction-Free Dual-ctDNA Detection via DNA Nanomaterial Fusion for Rapid Breast Cancer Diagnosis
ACS Nano · 2025
DOI: 10.1021/acsnano.5c11295 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, 2025. Verfasst von Xin Zhao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Med+X Center for Manufacturing, Department of General Surgery, National Clinical Research Center for Geriatrics, S…. Hauptthemen laut MEDLINE: Breast Neoplasms, Circulating Tumor DNA, Nanostructures, DNA. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: West China Hospital, Sichuan University, Natural Science Foundation of Sichuan Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
The rapid, sensitive, and multiplexed detection of circulating tumor DNA (ctDNA) is crucial for improving breast cancer diagnosis. Here, we present a homogeneous dual-signal sensing platform that integrates rolling circle amplification (RCA)-based DNA hydrogels and DNA@Cu2+ nanospheres (NS) for the simultaneous detection of dual ctDNA markers. This design enables a fully enzyme-free detection process after initial material synthesis, operating isothermally within 40 min and achieving an attomolar-level detection limit. The mechanism relies on target-triggered hydrogel disruption that exposes G-quadruplex sequences to enhance ThT fluorescence, while the concomitant release of Cu2+ quenches quantum dot emission, together enabling a self-referencing fluorescent output for improved accuracy. Clinical proof-of-concept validation was performed on a cohort of 58 breast cancer patients and 30 healthy controls, showing a sensitivity of 88.0% and a specificity of 93.3%, with high concordance to clinical and qPCR results. The platform effectively differentiated not only cancer patients from healthy individuals but also showed significant signal differences between early- and late-stage disease. With its minimal sample processing, low instrumental requirements, and reliable performance, this assay represents a promising concept for rapid, cost-effective prescreening and stratification in breast cancer management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Med+X Center for Manufacturing, Department of General Surgery, National Clinical Research Center for Geriatrics, State Key Laboratory of Respiratory Health and Multimorbidity, West Chi…
- Breast Disease Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
- Institute for Cancer Medicine, School of Basic Medical Sciences, Southwest Medical University, Luzhou, Sichuan 646000, China.
ORCID-Profile: Piaopiao Chen
Förderung
- West China Hospital, Sichuan University
- Natural Science Foundation of Sichuan Province
- National Natural Science Foundation of China
- Sichuan Provincial Science and Technology Support Program
- State Key Laboratory of Respiratory Health and Multimorbidity, West China Hospital, Sichuan University
- Med-X Center for Manufacturing, West China Hospital, Sichuan University
- National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University
Zitieren
APA
Zhao, X., Meng, X., Zeng, X., He, T., Chen, J., & Chen, P. (2025). Homogeneous Extraction-Free Dual-ctDNA Detection via DNA Nanomaterial Fusion for Rapid Breast Cancer Diagnosis. ACS Nano. https://doi.org/10.1021/acsnano.5c11295
Vancouver
Zhao X, Meng X, Zeng X, He T, Chen J, Chen P. Homogeneous Extraction-Free Dual-ctDNA Detection via DNA Nanomaterial Fusion for Rapid Breast Cancer Diagnosis. ACS Nano. 2025. doi:10.1021/acsnano.5c11295
BibTeX
@article{Zhao2025,
author = {Zhao, Xin and Meng, Xiangyue and Zeng, Xianghu and He, Tao and Chen, Jie and Chen, Piaopiao},
title = {Homogeneous Extraction-Free Dual-ctDNA Detection via DNA Nanomaterial Fusion for Rapid Breast Cancer Diagnosis},
journal = {ACS Nano},
year = {2025},
doi = {10.1021/acsnano.5c11295}
}
EUVIMED